This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Bronchus and lung
CD2_BENIGN_BRONCHUS_LUNG_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D14
- Name in latin
- Neoplasma benignum bronchi
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Bronchus and lung
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Bronchus and lung
- Benign neoplasm of middle ear and respiratory system
- Benign neoplasm of middle ear and respiratory system
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 464 | 200 | 264 |
| Unadjusted period prevalence (%) | 0.10 | 0.07 | 0.12 |
| Median age at first event (years) | 58.26 | 54.61 | 61.04 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 414
- Matched controls
- 4138
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D14.3
ICD-10 Finland
Benign neoplasm: Bronchus and lung
+∞
323.0
315
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
33.0
169.2
237
161
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
307.8
161.9
155
8
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
924.2
80.2
76
*
2123A
ICD-9 Finland
Benign neoplasm of respiratory and intrathoracic organs, Bronchus and lung
+∞
74.2
69
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
13.3
63.5
118
120
130
Kela drug reimbursment
Malignant tumour
+∞
41.3
39
*
GDA21
NOMESCO Finland
Thoracoscopic excision of lesion of lung
+∞
39.2
37
*
GDA20
NOMESCO Finland
Excision of lesion of lung
+∞
39.2
37
*
21230
ICD-8 Finland
Benign neoplasm of respiratory system, Bronchus and lung
+∞
33.8
32
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
69.0
28.3
32
5
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
25.3
24
*
5823
FHL
Lung avobiopsy and wedge resection
+∞
25.3
24
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
9.5
25.2
53
63
C61
ICD-10 Finland
Malignant neoplasm of prostate
253.8
23.9
24
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
19.0
23.1
35
20
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
22.0
215
1146
WX302
NOMESCO Finland
Thoracal epidural anesthesy
13.4
21.8
38
31
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
21.0
20
*
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
+∞
19.9
19
*
WX402
NOMESCO Finland
General anaesthesia
3.9
19.5
87
261
H02AB02
ATC
dexamethasone; systemic
22.1
18.9
27
13
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
104.8
18.7
20
*
GD1AD
NOMESCO Finland
Thorax CT examination
8.4
18.0
40
52
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
5.3
16.4
51
106
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
15.7
15
*
116
Kela drug reimbursment
Prostate cancer
+∞
15.7
15
*
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
13.1
15.1
26
21
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.1
14.8
90
339
XX3DW
NOMESCO Finland
Time consuming IT work
5.4
14.7
45
92
L01BC06
ATC
capecitabine; oral
+∞
14.7
14
*
A04AA02
ATC
granisetron; systemic, transdermal
155.1
14.5
15
*
GDC00
NOMESCO Finland
Lobectomy of lung
155.1
14.5
15
*
B01AB05
ATC
enoxaparin; parenteral
2.5
14.2
139
697
N02AX02
ATC
tramadol; systemic, rectal
2.3
13.9
197
1185
A03FA01
ATC
metoclopramide; systemic, rectal
3.4
13.8
70
231
5822
FHL
Exploratory thoracotomy and small procedure (eg lung suture)
144.4
13.5
14
*
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
6.5
13.2
34
56
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.2
12.9
40
83
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
72.1
12.7
14
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
12.6
12
*
WZC30
NOMESCO Finland
Teaching
3.6
12.4
58
179
1240
FHL
Bronchoscopy
12.9
12.2
21
17
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
11.8
113
552
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
11.5
11
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
11.5
11
*
115
Kela drug reimbursment
Breast cancer
+∞
11.5
11
*
5188X
ICD-9 Finland
Other diseases of lung
123.2
11.5
12
*
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
28.9
10.8
14
5
TPH07
NOMESCO Finland
Cathetrisation of artery
3.4
10.8
54
176
R4110
NOMESCO Finland
Physiotherapy
2.3
10.7
115
593
WF002
NOMESCO Finland
Radical radiotherapy
61.6
10.7
12
*
5826
FHL
Lobectomy or bilobectomy
+∞
10.5
10
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
10.5
10
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
10.5
10
*
JN4BD
NOMESCO Finland
Extensive body CT
4.3
10.4
38
94
51925
ICD-8 Finland
Other diseases of respiratory system, Infiltratio pulmonis NUD
33.4
10.4
13
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.3
9.9
50
164
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
102.2
9.4
10
*
WX250
NOMESCO Finland
Intercostal blockade
102.2
9.4
10
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
102.2
9.4
10
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
102.2
9.4
10
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
102.2
9.4
10
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
9.4
9
*
8240/3-C34.9
ICD-O-3
Neuroendocrine tumor, NOS, of lung, NOS
+∞
9.4
9
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
9.4
9
*
N02BE01
ATC
paracetamol; systemic, rectal
2.2
9.2
347
2896
JN4AD
NOMESCO Finland
Body CT examination
5.3
9.1
27
54
GDA10
NOMESCO Finland
Biopsy of lung
37.5
9.1
11
*
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
51.0
8.7
10
*
2391A
ICD-9 Finland
Neoplasm of unspecified nature, Respiratory system
28.1
8.5
11
*
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
91.8
8.4
9
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.5
8.4
67
292
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
8.4
8
*
GDB10
NOMESCO Finland
Wedge resection of lung
+∞
8.4
8
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
8.4
8
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
8.4
8
*
R05
ICD-10 Finland
Cough
2.2
8.3
88
444
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
34.0
8.1
10
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
7.8
81
405
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
15.4
7.8
12
8
L02AE02
ATC
leuprorelin; implant, parenteral
45.8
7.7
9
*
JN4CD
NOMESCO Finland
Very extensive body CT
7.9
7.4
16
21
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
7.3
7
*
23130
ICD-8 Finland
Neoplasm of unspecified nature of respiratory organs, Bronchus and lung
+∞
7.3
7
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
7.3
7
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
7.3
7
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
7.3
7
*
L02BB03
ATC
bicalutamide; oral
+∞
7.3
7
*
D38.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified
+∞
7.3
7
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
7.3
7
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
7.3
7
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.8
7.1
19
34
XG410
NOMESCO Finland
Flow-volume spirometry
3.8
6.9
28
78
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
40.7
6.8
8
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
17.0
6.8
10
6
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
6.3
6
*
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
+∞
6.3
6
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
6.3
6
*
D14.4
ICD-10 Finland
Benign neoplasm: Respiratory system, unspecified
+∞
6.3
6
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
6.3
6
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
+∞
6.3
6
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
6.3
6
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
+∞
6.3
6
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
6.3
6
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
12.8
6.1
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
31
21
15.75
35.11
1.3
1.3
45.3
15.4
ug/l
0.42
31
21
31
35
9.42
25.33
1.3
1.0
—
—
—
0
0
72
191
4.28
24.98
4.5
1.4
51.9
4.3
ug/l
0.54
64
153
50
115
4.75
20.67
2.4
3.3
—
—
—
0
0
18
13
14.36
19.45
2.8
1.8
3.9
4.1
nmol/l
0.03
18
13
101
407
2.89
18.00
8.6
6.3
1.7
1.5
mmol/l
0.10
87
312
233
1462
2.19
15.28
4.5
3.6
—
—
—
0
0
232
1459
2.18
15.06
4.9
3.6
35.5
35.7
g/l
0.16
214
1349
276
1863
2.19
14.90
7.7
6.2
4.4
4.3
e9/l
0.33
227
1619
81
333
2.74
13.68
10.1
7.0
124.7
123.3
g/l
0.23
81
324
31
70
4.67
13.04
2.2
1.4
—
—
—
0
0
232
1528
2.04
12.62
6.9
5.2
1.2
1.2
mmol/l
1.73
219
1358
249
1693
2.02
12.27
7.2
3.7
10.6
11.8
umol/l
1.78
241
1593
289
2086
2.02
11.86
6.5
4.2
6.8
6.8
mmol/l
0.05
277
1947
343
2661
2.11
11.19
9.0
5.3
80.6
75.6
u/l
1.73
329
2448
131
729
2.11
11.00
2.4
2.0
—
—
—
0
0
242
1691
1.90
10.39
8.8
5.7
1.2
1.2
mmol/l
1.92
206
1439
22
45
5.08
10.36
1.2
1.2
—
—
—
0
0
68
338
2.19
7.43
2.6
2.2
7.0
7.5
umol/l
0.19
58
292
12
9
13.65
7.42
4.7
5.6
—
—
—
0
0
21
66
3.29
5.66
2.2
2.5
16.4
16.8
%
0.11
12
36
91
553
1.80
5.55
2.1
1.8
—
—
—
0
0
64
349
1.97
5.45
3.7
3.1
—
—
—
0
0
36
156
2.42
5.41
7.8
4.6
2.0
1.6
%
1.42
36
150
24
85
2.92
5.33
1.6
2.0
134.4
131.0
g/l
0.17
14
62
80
481
1.80
5.04
4.6
2.6
0.8
0.8
mmol/l
1.66
71
445
8
8
10.15
4.53
2.4
1.0
59.9
75.8
nmol/l
—
8
8
105
701
1.64
4.52
1.7
1.6
1.3
1.0
mg/l
0.51
81
550
17
55
3.17
4.40
2.5
3.0
4.3
4.7
e9/l
0.23
17
55
47
250
1.98
4.30
9.1
6.7
25.3
24.6
mmol/l
0.82
47
232
22
84
2.70
4.29
1.4
1.5
—
—
—
0
0
17
56
3.11
4.28
2.5
3.3
56.7
59.8
%
0.37
17
56
134
962
1.55
4.23
4.0
2.8
0.5
0.5
e6/l
0.12
99
718
18
63
2.93
4.11
1.8
1.3
—
—
—
0
0
71
441
1.72
3.99
2.6
2.5
23.3
23.6
%
0.06
61
376
309
2662
1.48
3.83
4.7
4.1
12.3
12.0
mm/h
0.13
291
2420
142
1060
1.49
3.66
3.8
2.0
2.4
2.4
mmol/l
0.40
129
881
80
528
1.62
3.57
3.8
2.8
2.3
2.0
e6/l
0.12
40
285
38
201
1.97
3.56
1.7
1.7
—
—
—
0
0
46
262
1.84
3.46
3.1
2.4
1.2
1.2
mmol/l
0.13
41
219
16
58
2.82
3.45
1.8
1.2
—
—
—
0
0
232
1917
1.42
3.44
2.9
2.6
—
—
—
0
0
149
1138
1.46
3.38
3.1
2.2
56.7
57.0
u/l
0.04
141
1054
8
14
5.79
3.35
1.0
1.1
—
—
—
0
0
13
43
3.08
3.27
1.9
1.4
306.5
321.0
pmol/l
—
8
33
39
218
1.86
3.12
1.4
1.2
187.0
223.0
u/ml
0.22
34
199
89
624
1.53
3.06
3.0
2.2
2.5
2.4
mmol/l
1.17
80
527
185
1496
1.39
2.99
4.4
3.8
27.6
67.3
ng/l
1.07
140
1086
148
1157
1.41
2.89
3.1
3.0
1128.9
1538.4
ng/l
1.20
131
972
39
227
1.78
2.77
3.1
3.7
2.4
2.0
mmol/l
0.27
32
169
5
6
8.41
2.75
8.6
1.0
—
—
—
0
0
385
3549
1.50
2.73
21.7
12.5
25.0
23.7
mg/l
0.34
343
2751
60
398
1.58
2.63
1.8
1.8
—
—
—
0
0
157
1257
1.38
2.63
4.0
2.9
—
—
—
0
0
29
498
0.55
2.49
6.8
6.8
—
—
—
0
0
15
63
2.43
2.48
1.9
1.3
—
—
—
0
0
17
77
2.25
2.40
1.6
1.7
2.5
4.5
iu/l
—
5
27
6
13
4.66
2.28
1.8
1.5
2.9
4.1
mg/l
—
6
13
94
706
1.42
2.27
4.2
3.9
229.5
360.5
ng/l
0.43
77
567
16
73
2.23
2.23
1.7
1.3
—
—
—
0
0
36
219
1.70
2.23
2.2
1.5
—
—
—
0
0
13
54
2.45
2.21
1.7
1.4
—
—
—
0
0
58
398
1.52
2.21
1.9
1.7
—
—
—
0
0
8
24
3.37
2.19
1.0
1.1
—
—
—
0
0
43
276
1.61
2.18
2.2
2.0
43.8
31.4
u/l
0.56
37
227
79
579
1.44
2.18
3.7
2.6
1.5
1.1
e6/l
0.39
39
334
7
19
3.72
2.16
1.1
1.3
—
—
—
0
0
12
51
2.39
1.96
1.1
1.2
—
—
—
0
0
16
78
2.09
1.93
1.2
1.1
—
—
—
0
0
18
92
2.00
1.92
1.3
1.4
—
1.1
—
0
10
8
28
2.89
1.87
1.0
1.0
—
—
—
0
0
8
28
2.89
1.87
2.6
1.5
—
—
—
0
0
11
46
2.43
1.86
2.2
1.2
—
—
—
0
0
18
94
1.95
1.82
1.5
1.4
49.1
52.1
mg/l
0.08
13
79
18
94
1.95
1.82
1.4
1.4
37.2
37.5
mg/l
0.01
13
79
25
146
1.75
1.81
2.1
2.2
32.4
40.9
u/l
1.12
20
130
364
3395
1.33
1.79
18.7
11.3
80.1
77.6
ml/min/173m2
1.62
319
2732
5
13
3.88
1.72
1.4
1.1
—
—
—
0
0
5
13
3.88
1.72
1.4
1.1
—
—
—
0
0
5
13
3.88
1.72
1.4
1.1
—
—
—
0
0
5
13
3.88
1.72
1.4
1.1
—
—
—
0
0
5
14
3.60
1.62
1.2
1.4
—
—
—
0
0
5
14
3.60
1.62
1.2
1.4
—
—
—
0
0
8
32
2.53
1.60
2.6
1.3
—
—
—
0
0
0
44
0.00
1.52
0.0
1.0
—
—
—
0
0
10
45
2.25
1.47
2.3
1.3
—
—
—
0
0
9
38
2.40
1.46
2.4
1.3
—
—
—
0
0
51
374
1.41
1.44
1.9
1.9
1.4
1.6
%
1.11
43
318
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
89
1.83
1.39
4.4
2.7
0.6
0.3
u/ml
—
8
48
397
3788
1.33
1.38
23.8
15.1
139.4
139.8
mmol/l
2.41
392
3679
35
488
0.69
1.27
5.7
4.9
36.6
31.9
%
1.35
24
322
9
44
2.07
1.27
1.1
1.2
—
—
—
0
0
397
3800
1.31
1.25
24.0
15.1
4.0
4.0
mmol/l
0.93
391
3684
163
1437
1.21
1.13
3.2
2.7
127.3
135.0
ug/l
0.18
156
1313
5
21
2.40
1.09
1.0
1.2
—
—
—
0
0
247
2275
1.18
1.03
5.6
4.0
26.3
2450.0
e6/l
—
6
36
7
35
2.01
1.00
4.7
2.4
—
591.0
—
0
7
5
23
2.19
0.98
1.2
1.5
—
—
—
0
0
5
23
2.19
0.98
1.2
1.3
1.0
1.0
g/l
—
5
23
338
3208
1.20
0.96
21.7
13.5
39.5
40.1
%
0.51
240
2177
10
56
1.80
0.88
1.4
1.2
—
—
—
0
0
8
43
1.88
0.87
1.0
1.1
—
—
—
0
0
19
128
1.51
0.87
3.3
1.6
—
—
—
0
0
360
3739
0.83
0.86
5.3
5.3
2.7
2.7
mmol/l
0.28
331
3432
6
32
1.89
0.82
1.0
1.2
—
—
—
0
0
100
868
1.19
0.81
2.3
2.2
3.0
3.0
mg/l
0.02
87
731
398
3855
1.23
0.81
12.8
8.8
26.6
26.0
u/l
0.26
388
3692
129
1147
1.17
0.80
2.4
2.1
305.7
256.6
u/l
0.16
123
1070
20
279
0.70
0.78
1.7
1.8
—
—
—
0
0
245
2289
1.15
0.77
3.7
3.0
57.1
49.9
u/l
0.40
233
2124
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
9
54
1.68
0.75
1.0
1.3
—
0.7
nmol/l
—
0
5
5
24
2.09
0.74
1.4
1.8
—
—
—
0
0
397
3852
1.21
0.74
24.1
14.5
79.1
80.5
umol/l
0.31
397
3852
44
354
1.27
0.74
5.1
3.4
0.8
2.2
mmol/l
0.73
33
296
107
944
1.17
0.73
4.3
3.6
0.0
0.0
estimate
0.00
45
278
5
25
2.01
0.73
1.4
1.0
—
—
—
0
0
5
25
2.01
0.73
1.4
1.0
—
—
—
0
0
5
25
2.01
0.73
1.4
1.0
—
—
—
0
0
5
25
2.01
0.73
2.4
2.7
13.4
13.4
%
—
5
25
99
870
1.18
0.71
2.7
2.6
0.6
0.7
ug/l
1.45
68
576
355
3670
0.86
0.67
4.6
4.7
4.5
4.6
mmol/l
0.57
329
3382
12
78
1.55
0.66
1.0
1.6
—
—
—
0
0
6
101
0.59
0.63
1.0
1.3
—
—
—
0
0
353
3645
0.87
0.62
4.6
4.7
1.4
1.4
mmol/l
0.44
324
3344
285
2714
1.13
0.62
4.0
3.7
14.9
14.9
pmol/l
0.03
256
2436
5
30
1.67
0.61
1.0
1.2
—
—
—
0
0
187
1737
1.13
0.61
5.2
4.8
0.0
0.0
estimate
0.00
48
284
17
122
1.41
0.61
3.4
1.5
—
—
—
0
0
14
98
1.44
0.57
1.0
1.2
—
—
—
0
0
5
88
0.56
0.56
1.2
1.3
7.6
1339.1
e6/l
—
5
75
5
88
0.56
0.56
1.2
1.2
2.4
59.4
e6/l
—
5
73
6
38
1.59
0.54
1.2
1.2
—
—
—
0
0
6
38
1.59
0.54
1.2
1.2
—
—
—
0
0
6
38
1.59
0.54
1.2
1.2
—
—
—
0
0
9
62
1.46
0.53
1.4
1.7
—
—
—
0
0
12
83
1.46
0.52
4.4
3.2
0.9
0.8
nmol/l
0.15
12
66
184
1726
1.11
0.49
3.9
3.5
0.0
0.0
estimate
0.00
47
285
19
145
1.32
0.49
5.4
3.8
1.2
1.3
mmol/l
0.34
19
140
23
289
0.79
0.49
2.2
2.0
90.2
65.4
ml/min/173m2
1.38
13
111
5
85
0.58
0.45
1.6
1.4
—
—
—
0
0
46
398
1.17
0.43
1.3
1.4
—
—
—
0
0
8
56
1.44
0.42
6.9
4.8
381.3
344.5
umol/l
—
8
48
109
1002
1.11
0.42
1.6
1.7
1.5
1.4
mmol/l
0.52
82
834
5
32
1.57
0.42
3.0
2.4
—
—
—
0
0
186
1759
1.10
0.42
4.0
3.5
0.0
0.0
estimate
0.50
42
278
135
1257
1.10
0.42
4.2
3.6
20.5
24.2
%
2.26
66
576
104
955
1.11
0.41
2.8
2.4
8655.2
8826.3
umol/l
0.01
95
829
0
15
0.00
0.41
0.0
2.3
—
—
—
0
0
17
216
0.78
0.41
1.4
1.8
—
—
—
0
0
5
34
1.48
0.40
1.0
1.1
—
—
—
0
0
5
34
1.48
0.40
1.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
5
36
1.39
0.38
1.0
1.2
—
—
—
0
0
26
216
1.22
0.37
1.8
1.5
—
—
—
0
0
15
191
0.78
0.37
1.4
1.7
—
—
—
0
0
5
37
1.36
0.37
1.0
1.2
—
—
—
0
0
5
37
1.36
0.37
1.0
1.2
—
—
—
0
0
165
1562
1.09
0.36
4.5
3.8
2.1
1.9
ug/l
0.35
148
1394
67
606
1.12
0.35
1.3
1.3
78.3
37.6
iu/ml
0.43
19
190
6
43
1.40
0.35
1.0
1.3
—
—
—
0
0
6
43
1.40
0.35
2.2
3.4
—
—
—
0
0
81
744
1.11
0.33
1.9
1.8
1114.3
1187.2
nmol/l
0.36
62
568
6
46
1.31
0.33
1.0
1.3
—
—
—
0
0
75
817
0.90
0.32
2.2
1.8
398.1
27647482.7
pmol/l
1.00
63
680
13
164
0.79
0.31
1.4
1.3
—
—
—
0
0
53
477
1.13
0.31
1.4
1.4
—
—
—
0
0
8
110
0.72
0.29
1.3
1.2
—
—
—
0
0
8
110
0.72
0.29
1.3
1.2
—
—
—
0
0
344
3508
0.93
0.28
4.1
4.2
1.3
1.3
mmol/l
0.09
310
3195
12
94
1.28
0.28
1.5
1.2
0.0
0.0
g/l
0.00
12
89
9
120
0.75
0.27
1.9
1.8
42.3
40.6
nmol/l
—
9
115
8
65
1.23
0.27
1.3
1.5
—
—
—
0
0
8
65
1.23
0.27
1.3
1.5
—
—
—
0
0
9
73
1.24
0.25
1.0
1.2
—
—
—
0
0
338
3315
1.07
0.25
4.9
4.5
1.8
2.0
mu/l
0.99
310
2990
12
96
1.26
0.24
1.5
1.2
0.0
0.0
g/l
0.00
12
90
9
77
1.17
0.24
1.2
1.3
—
—
—
0
0
6
82
0.73
0.24
1.5
2.0
—
—
—
0
0
15
125
1.21
0.22
1.4
1.3
8.6
11.1
g/l
2.34
15
109
146
1400
1.06
0.22
2.7
2.3
77.3
77.7
nmol/l
0.05
129
1224
0
11
0.00
0.21
0.0
1.1
—
9.5
—
0
11
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
123
1285
0.94
0.20
4.2
3.9
6.7
8.1
mg/mmol
0.21
84
808
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
6
51
1.18
0.19
1.2
1.0
—
—
—
0
0
22
194
1.14
0.19
1.2
1.2
41.9
108.2
iu/ml
—
6
76
5
68
0.73
0.17
1.0
2.0
—
—
—
0
0
18
159
1.14
0.15
3.2
4.2
25.4
25.0
mmol/l
0.23
18
146
12
102
1.18
0.15
1.5
1.3
0.0
0.0
g/l
0.00
12
96
67
705
0.94
0.15
1.4
1.2
0.6
1.8
u/ml
2.35
23
201
7
87
0.80
0.14
1.3
1.3
—
—
—
0
0
17
150
1.14
0.14
1.0
1.1
—
—
—
0
0
56
585
0.95
0.10
1.3
1.3
17.6
12.5
u/ml
0.23
17
213
366
3631
1.04
0.10
5.0
4.8
6.0
6.0
mmol/l
0.11
333
3293
5
48
1.04
0.09
1.0
1.1
—
140.2
—
0
11
15
136
1.11
0.08
1.4
1.3
—
—
—
0
0
12
133
0.90
0.07
1.3
1.7
2.4
2.8
mg/l
0.19
12
95
11
98
1.13
0.07
1.5
1.7
0.0
0.2
iu/ml
—
5
20
8
75
1.07
0.07
1.1
1.3
—
49.4
—
0
6
12
108
1.11
0.07
1.5
1.2
37.3
37.8
g/l
0.11
12
93
21
196
1.07
0.07
2.9
2.4
1.0
1.2
%
0.77
21
196
7
82
0.85
0.07
1.1
1.5
1.1
0.9
nmol/l
—
7
67
8
94
0.85
0.06
1.0
1.1
—
17.4
—
0
8
13
119
1.10
0.06
2.0
1.9
—
—
—
0
0
12
110
1.09
0.05
1.5
1.3
0.8
0.3
g/l
0.66
12
100
90
915
0.98
0.04
1.7
1.5
18.6
20.9
nmol/l
0.94
81
780
348
3466
1.02
0.03
6.1
6.2
40.8
40.5
mmol/mol
0.21
321
3214
124
1254
0.98
0.03
3.4
3.1
7.6
7.8
mmol/l
0.21
102
1043
138
1366
1.01
0.03
4.2
3.6
—
—
—
0
0
35
359
0.97
0.02
2.4
2.7
6.4
7.7
ug/l
0.36
30
308
156
1552
1.01
0.01
1.9
2.0
97.5
93.4
pmol/l
0.47
84
794
13
126
1.03
0.00
1.5
1.3
3.4
3.1
g/l
0.34
13
100
15
148
1.01
0.00
2.2
2.1
1401.4
556.1
ug/l
0.30
15
136
8
89
0.90
0.00
1.5
1.8
244.9
230.7
pmol/l
—
8
82
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
3.6
—
0
6
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
9
96
0.94
0.00
1.3
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
9
99
0.91
0.00
1.9
1.6
—
—
—
0
0
8
84
0.95
0.00
1.5
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_BRONCHUS_LUNG_EXALLC – Benign neoplasm: Bronchus and lung
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).